Organicell Regenerative Medicine (OCEL) Competitor Comparison
We are evaluating the key criteria listed to compare Organicell Regenerative Medicine (OCEL) against its competitors in the Biotechnology industry.
Market Capitalization
331 / 368Gross Profits
108 / 278Total Revenue
202 / 300EBITDA
50 / 337Free Cashflow
67 / 352Quick Ratio
352 / 357Earnings per Share
358 / 359Dividend yield
0 / 6Total Cash
351 / 358Performance 3 years
357 / 368Performance 5 years
246 / 368Performance 10 years
185 / 368Linearity 3 years
325 / 368Linearity 5 years
72 / 368Linearity 10 years
101 / 368Total Rank
220 / 368Dividend Rank
230 / 368Valuation Rank
21 / 368Piotroski Rank
152 / 368Muliplier Rank
174 / 368Piotroski Rank - OCEL ranking 152 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.